Press release
Leading Element Driving Change in the Multidrug Resistant Bacteria Market in 2025: Surging Prevalence Of Infectious Diseases Accelerates Growth In Multidrug-Resistant Bacteria Market Driver
Multidrug Resistant Bacteria Market
The multidrug-resistant bacteria market has grown steadily in recent years. It is expected to increase from $12.61 billion in 2024 to $13.4 billion in 2025, with a CAGR of 6.2%. The historical growth was driven by the ongoing antibiotic resistance crisis, advancements in drug discovery, regulatory incentives, and public health initiatives.
The multidrug-resistant bacteria market is forecasted to grow to $17.5 billion by 2029, with a CAGR of 6.9%. Growth factors include antibiotic stewardship programs, the global spread of resistance, the use of phage therapy and alternative treatments, and increased investments from both public and private sectors. Trends to watch will include precision medicine for infectious diseases, combination therapies, continuous surveillance and monitoring, and global cooperation efforts.
What Are the Forces Behind the Rapid Growth of the Multidrug Resistant Bacteria Market?
The rising prevalence of infectious diseases is expected to drive the multidrug-resistant bacteria market. Infectious diseases are caused by bacteria, viruses, fungi, or parasites. Multidrug-resistant bacteria complicate treatment by developing resistance to multiple antibiotics, rendering conventional therapies ineffective. For example, in November 2023, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported an increase in tuberculosis cases in the USA from 8,320 in 2022 to 9,615 in 2023-an uptick of 1,295 cases. Consequently, the escalating burden of infectious diseases is driving the multidrug-resistant bacteria market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13044&type=smp
Who Are the Dominant Companies Influencing Multidrug Resistant Bacteria Market Trends?
Major players in the multidrug resistant bacteria market are Pfizer Inc., Johnson And Johnson Private Limited, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy's Laboratories Ltd., Lupin Pharmaceuticals Inc., BioMarin Pharmaceuticals Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Alkem Laboratories, Wockhardt Ltd., Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Theravance Biopharma Inc., Melinta Therapeutics Inc., Armata Pharmaceuticals Inc., Tetraphase Pharmaceuticals Inc.
How Is the Multidrug Resistant Bacteria Market Evolving?
Major players in the multidrug-resistant bacteria market are focusing on drug development and regulatory approvals to address antibiotic resistance. Regulatory approvals for multidrug-resistant bacteria treatments are crucial in combating antibiotic resistance. For instance, in May 2023, Entasis Therapeutics Inc., a US-based biotech firm, secured FDA approval for Xacduor, a combination antibiotic for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by Acinetobacter baumannii. This drug, composed of ceftolozane and tedizolid phosphate, provides a novel treatment option for patients with antibiotic-resistant Acinetobacter infections. Additionally, it incorporates a combination of the beta-lactam antibiotic sulbactam with the beta-lactamase inhibitor durlobactam to enhance efficacy against resistant strains.
What Are the Different Segmentations in the Multidrug Resistant Bacteria Market?
The multidrug resistant bacteria market covered in this report is segmented -
1) By Disease: Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, Acute Bacterial Skin And Skin Structure Infections, Hospital Acquired Bacterial Pneumonia, Acquired Bacterial Pneumonia, Other Diseases
2) By Drug Class: Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination Therapies, Other Drug Classes
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Urinary Tract Infection: Cystitis, Pyelonephritis
2) By Intra-Abdominal Infections: Appendicitis, Peritonitis
3) By Blood Stream Infections: Bacteremia, Sepsis
4) By Clostridium Difficile Infections: Mild CDI, Severe CDI
5) By Acute Bacterial Skin And Skin Structure Infections: Cellulitis, Abscesses
6) By Hospital Acquired Bacterial Pneumonia: Ventilator-Associated Pneumonia, Hospital-Acquired Pneumonia
7) By Acquired Bacterial Pneumonia: Community-Acquired Pneumonia, Aspiration Pneumonia
By Other Diseases: Bone and Joint Infections, Endocarditis
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/multidrug-resistant-bacteria-global-market-report
Which Region Is at the Forefront of the Multidrug Resistant Bacteria Market?
North America was the largest region in the multidrug-resistant bacteria market in 2024. The regions covered in multidrug-resistant bacteria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Multidrug Resistant Bacteria Global Market Report?
- Market Size Analysis: Analyze the Multidrug Resistant Bacteria Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Multidrug Resistant Bacteria Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Multidrug Resistant Bacteria Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Multidrug Resistant Bacteria Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13044
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Element Driving Change in the Multidrug Resistant Bacteria Market in 2025: Surging Prevalence Of Infectious Diseases Accelerates Growth In Multidrug-Resistant Bacteria Market Driver here
News-ID: 3855457 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Bacteria
Global Live Beneficial Bacteria Market Size by Application, Type, and Geography: …
USA, New Jersey- According to Market Research Intellect, the global Live Beneficial Bacteria market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The live beneficial bacteria market has seen substantial growth, driven by the increasing awareness of gut health and the rising demand for probiotics and…
Global Bacteria Analyzer Market - Forecast to 2026
According to a new market research report published by Global Market Estimates, the Global Bacteria Analyzer Market is projected to grow from USD 214.2 million in 2021 to USD 225.34 million by 2026 at a CAGR value of 5.2% between 2021 to 2026. Increasing concerns of contaminated products from various verticals are increasing the demand for bacteria analyzers. The presence of unidentified bacterial microorganisms in various end products is the…
Bacteria as CO2 recycling powerhouse
E. coli can live and feed on formate & methanol:
Scientists from the Max Planck Institute (Germany) have reached a significant breakthrough presented in their recent Nature Chemical Biology publication. Their research for EU project eForFuel has redesigned the model biotechnological bacteria Escherichia coli (E. coli) to live and feed on methanol and formate: a possibility that serves as a stepping stone towards future endeavors aiming at recycling CO2 into various…
Bacteria Analyzer Market Size: Opportunities and Challenges
A recent market study published by QY Research consists of a detailed assessment of the key market dynamics. The report provides the historical as well as present growth parameters of the global Bacteria Analyzer market. The report features salient and unique factors, which are expected to significantly impact the growth of the global Bacteria Analyzer market throughout the forecast period.
Scope of the report:
The report commences with a scope of the…
Bacteria Sourced Microbial Lipase Market
https://www.qandqmarketresearch.com/reports/7482906/bacteria-sourced-microbial-lipase-market-55
The global Bacteria Sourced Microbial Lipase market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 20192025. The objectives of this study are to define, segment, and project the size of the Bacteria Sourced Microbial Lipase market based on company, product type, end user and key regions.
This report studies the global market size of Bacteria Sourced…
Bacteria, deadwood and climate changeT
With the support of the Austrian Science Fund FWF, an international group of researchers is investigating to what extent the forest floor serves as a carbon sink and how bacteria and fungi interact in this context. The researchers have found deadwood to be populated by a great diversity of life.
"The wealth of microorganisms we found in deadwood was astounding", says the microbiologist Judith Ascher-Jenull. It has long been known…
